PubMed

Photodynamic therapy with topical metatetrahydroxychlorin (Fosgel) is ineffective for the treatment of anal intraepithelial neoplasia, grade III.

van der Snoek EM, Amelink A, van der Ende ME, den Hollander JC, den Hollander JG, Kroon FP, Vriesendorp R, Neumann HA, Robinson DJ.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):141-3. No abstract available. PMID: 19704267 [PubMed - indexed for MEDLINE]Related articles

Early versus deferred antiretroviral therapy for HIV.

Gelinck LB, van der Ende ME.

N Engl J Med. 2009 Aug 20;361(8):823; author reply 823-4. No abstract available. PMID: 19701986 [PubMed - indexed for MEDLINE]Related articles

Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir.

van Vonderen MG, Gras L, Wit F, Brinkman K, van der Ende ME, Hoepelman AI, de Wolf F, Reiss P.

HIV Clin Trials. 2009 May-Jun;10(3):168-80.PMID: 19632956 [PubMed - indexed for MEDLINE]Related articles

Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations.

van Luin M, Gras L, Richter C, Ende ME, Prins JM, Wolf FD, Burger DM, Wit FW.

J Acquir Immune Defic Syndr. 2009 Jul 10. [Epub ahead of print]PMID: 19593159 [PubMed - as supplied by publisher]Related articles

The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women.

van der Lugt J, Colbers A, Molto J, Hawkins D, van der Ende M, Vogel M, Wyen C, Schutz M, Koopmans P, Ruxrungtham K, Richter C, Burger D; SARA study team.

Antivir Ther. 2009;14(3):443-50.PMID: 19474478 [PubMed - indexed for MEDLINE]Related articles

Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy.

Arends JE, Stuart JC, Baak LC, van der Ende ME, van Erpecum KJ, Simons CP, Boland GJ, van Baarle D, Hoepelman AI.

J Viral Hepat. 2009 Dec;16(12):867-75. Epub 2009 May 11.PMID: 19457139 [PubMed - in process]Related articles

Long-term survival after kidney transplantation in an HIV-positive patient.

Roefs A, van der Ende M, IJzermans J, Weimar W, van Gelder T.

Clin Transplant. 2009 Mar;23(2):278-81. Epub 2009 Feb 11.PMID: 19220363 [PubMed - indexed for MEDLINE]Related articles

Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.

de Boer-van der Kolk IM, Sprangers MA, van der Ende M, Schreij G, de Wolf F, Nieuwkerk PT.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):460-2. No abstract available. PMID: 19011424 [PubMed - indexed for MEDLINE]Related articles

Prevention of atherosclerosis in LDL receptor-mutant mice by human umbilical cord blood cells.

Ende N, Ende M, Chen R, Coakley K, Reddi AS.

Res Commun Mol Pathol Pharmacol. 2005;117-118:125-36.PMID: 18426084 [PubMed - indexed for MEDLINE]Related articles

Steady-state nevirapine plasma concentrations are influenced by pregnancy.

Nellen JF, Damming M, Godfried MH, Boer K, van der Ende ME, Burger DM, de Wolf F, Wit FW, Prins JM.

HIV Med. 2008 Apr;9(4):234-8.PMID: 18366447 [PubMed - indexed for MEDLINE]Related articles

CCR5-restricted HIV type 2 variants from long-term aviremic individuals are less sensitive to inhibition by beta-chemokines than low pathogenic HIV type 1 variants.

Blaak H, Boers PH, van der Ende ME, Schuitemaker H, Osterhaus AD.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):473-84.PMID: 18327978 [PubMed - indexed for MEDLINE]Related articles

Immunologic, virologic, and clinical consequences of episodes of transient viremia during suppressive combination antiretroviral therapy.

van Sighem A, Zhang S, Reiss P, Gras L, van der Ende M, Kroon F, Prins J, de Wolf F.

J Acquir Immune Defic Syndr. 2008 May 1;48(1):104-8.PMID: 18285709 [PubMed - indexed for MEDLINE]Related articles

Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.

Wit FW, Kesselring AM, Gras L, Richter C, van der Ende ME, Brinkman K, Lange JM, de Wolf F, Reiss P.

Clin Infect Dis. 2008 Mar 15;46(6):933-40.PMID: 18271750 [PubMed - indexed for MEDLINE]Related articles

A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.

de Vries-Sluijs TE, Hansen BE, van Doornum GJ, Springeling T, Evertsz NM, de Man RA, van der Ende ME.

J Infect Dis. 2008 Jan 15;197(2):292-4.PMID: 18177248 [PubMed - indexed for MEDLINE]Related articles

Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice.

Cleijsen RM, van de Ende ME, Kroon FP, Lunel FV, Koopmans PP, Gras L, de Wolf F, Burger DM.

J Antimicrob Chemother. 2007 Oct;60(4):897-900. Epub 2007 Aug 17.PMID: 17704117 [PubMed - indexed for MEDLINE]Related articlesFree article

Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha.

van der Ende M, Mulder JW, van den Berge M, Blok W, Schutten M.

AIDS. 2007 Jul 31;21(12):1661-2. No abstract available. PMID: 17630571 [PubMed - indexed for MEDLINE]Related articles

The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.

Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, Sluman MA, van der Ende ME, Godfried MH.

BJOG. 2007 Feb;114(2):148-55.PMID: 17305888 [PubMed - indexed for MEDLINE]Related articles

Rapid antibiotic sensitivity testing and trimethoprim-mediated filamentation of clinical isolates of the Enterobacteriaceae assayed on a novel porous culture support.

Ingham CJ, van den Ende M, Wever PC, Schneeberger PM.

J Med Microbiol. 2006 Nov;55(Pt 11):1511-9.PMID: 17030910 [PubMed - indexed for MEDLINE]Related articlesFree article

Hematopoietic stem-cell transplantation.

Ende M, Ende FI.

N Engl J Med. 2006 Sep 7;355(10):1070; author reply 1070-1. No abstract available. PMID: 16960981 [PubMed - indexed for MEDLINE]Related articles

In vitro replication capacity of HIV-2 variants from long-term aviremic individuals.

Blaak H, van der Ende ME, Boers PH, Schuitemaker H, Osterhaus AD.

Virology. 2006 Sep 15;353(1):144-54. Epub 2006 Jun 30.PMID: 16814357 [PubMed - indexed for MEDLINE]Related articles

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism.

Burger D, van der Heiden I, la Porte C, van der Ende M, Groeneveld P, Richter C, Koopmans P, Kroon F, Sprenger H, Lindemans J, Schenk P, van Schaik R.

Br J Clin Pharmacol. 2006 Feb;61(2):148-54.PMID: 16433869 [PubMed - indexed for MEDLINE]Related articlesFree article

Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.

de Vries-Sluijs TE, van der Eijk AA, Hansen BE, Osterhaus AD, de Man RA, van der Ende ME.

J Clin Virol. 2006 May;36(1):60-3. Epub 2006 Jan 18.PMID: 16418013 [PubMed - indexed for MEDLINE]Related articles

Growth and multiplexed analysis of microorganisms on a subdivided, highly porous, inorganic chip manufactured from anopore.

Ingham CJ, van den Ende M, Pijnenburg D, Wever PC, Schneeberger PM.

Appl Environ Microbiol. 2005 Dec;71(12):8978-81.PMID: 16332904 [PubMed - indexed for MEDLINE]Related articlesFree article

[Anorectal malignancies and dysplasia in HIV-positive men who have sex with men]

van der Snoek EM, van der Ende ME, Schouten WR, den Hollander JC, van der Meijden WI.

Ned Tijdschr Geneeskd. 2005 Sep 3;149(36):1989-93. Review. Dutch. PMID: 16171110 [PubMed - indexed for MEDLINE]Related articles

Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.

van der Eijk AA, Hansen BE, Niesters HG, Janssen HL, van de Ende M, Schalm SW, de Man RA.

J Viral Hepat. 2005 Jul;12(4):364-72.PMID: 15985006 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications.

la Porte CJ, Schippers EF, van der Ende ME, Koopmans PP, Blok WL, Kauffmann RH, Kroon FP, Burger DM.

AIDS. 2005 Jul 1;19(10):1105-7.PMID: 15958844 [PubMed - indexed for MEDLINE]Related articles

Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study.

Crommentuyn KM, Huitema AD, Brinkman K, van der Ende ME, de Wolf F, Beijnen JH; Athena study.

J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):249-50. No abstract available. PMID: 15905743 [PubMed - indexed for MEDLINE]Related articles

Nelfinavir and nevirapine side effects during pregnancy.

Timmermans S, Tempelman C, Godfried MH, Nellen J, Dieleman J, Sprenger H, Schneider ME, de Wolf F, Boer K, van der Ende ME; Dutch HMF Study Group.

AIDS. 2005 May 20;19(8):795-9.PMID: 15867493 [PubMed - indexed for MEDLINE]Related articles

Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy.

den Hollander JG, Rijnders BJ, van Doornum GJ, van der Ende ME.

AIDS. 2005 Mar 24;19(6):639-40. No abstract available. PMID: 15802989 [PubMed - indexed for MEDLINE]Related articles

Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.

Wit FW, Blanckenberg DH, Brinkman K, Prins JM, van der Ende ME, Schneider MM, Mulder JW, de Wolf F, Lange JM; ATHENA Study Group.

AIDS. 2005 Feb 18;19(3):345-8.PMID: 15718848 [PubMed - indexed for MEDLINE]Related articles

CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.

Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, Osterhaus AD.

J Virol. 2005 Feb;79(3):1686-700.PMID: 15650194 [PubMed - indexed for MEDLINE]Related articlesFree article

[Liver transplantation in a HIV-positive patient receiving potent antiretroviral therapy; the first case in The Netherlands]

Honkoop P, Kazemier G, Perenboom RM, van de Ende ME, de Man RA.

Ned Tijdschr Geneeskd. 2004 Dec 11;148(50):2500-4. Dutch. PMID: 15638199 [PubMed - indexed for MEDLINE]Related articles

[Sexual transmission of hepatitis C in homosexual men]

Ruys TA, den Hollander JG, Beld MG, van der Ende ME, van der Meer JT.

Ned Tijdschr Geneeskd. 2004 Nov 20;148(47):2309-12. Dutch. PMID: 15587046 [PubMed - indexed for MEDLINE]Related articles

Management of the acute radiation syndrome.

Ende M.

Ann Intern Med. 2004 Dec 7;141(11):891. No abstract available. PMID: 15583241 [PubMed - indexed for MEDLINE]Related articlesFree article

[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects]

Tempelman C, Timmermans S, Godfried MH, Dieleman JP, Boer K, van der Ende ME.

Ned Tijdschr Geneeskd. 2004 Oct 9;148(41):2021-5. Dutch. PMID: 15553999 [PubMed - indexed for MEDLINE]Related articles

Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy.

van Leth F, Wit FW, Reiss P, Schattenkerk JK, van der Ende ME, Schneider MM, Mulder JW, Frissen PH, de Wolf F, Lange JM.

HIV Med. 2004 Mar;5(2):74-81.PMID: 15012645 [PubMed - indexed for MEDLINE]Related articles

The effect of nevirapine on the pharmacokinetics of indinavir/ritonavir 800/100 mg BID.

Burger DM, Prins JM, van der Ende ME, Aarnoutse RE.

J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):97-8. No abstract available. PMID: 14707800 [PubMed - indexed for MEDLINE]Related articles

A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).

Burger DM, Aarnoutse RE, Dieleman JP, Gyssens IC, Nouwen J, de Marie S, Koopmans PP, Stek M Jr, van der Ende ME.

Antivir Ther. 2003 Oct;8(5):455-61.PMID: 14640393 [PubMed - indexed for MEDLINE]Related articles

Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients.

van der Ende ME, Prins JM, Brinkman K, Keuter M, Veenstra J, Danner SA, Niesters HG, Osterhaus AD, Schutten M.

AIDS. 2003 Jul;17 Suppl 3:S55-61.PMID: 14565610 [PubMed - indexed for MEDLINE]Related articles

Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population.

de Vries-Sluijs TE, Dieleman JP, Arts D, Huitema AD, Beijnen JH, Schutten M, van der Ende ME.

Clin Pharmacokinet. 2003;42(6):599-605.PMID: 12793844 [PubMed - indexed for MEDLINE]Related articles

Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations.

Burger DM, Hugen PW, Aarnoutse RE, Hoetelmans RM, Jambroes M, Nieuwkerk PT, Schreij G, Schneider MM, van der Ende ME, Lange JM; ATHENA Study Group.

Ther Drug Monit. 2003 Feb;25(1):73-80.PMID: 12548148 [PubMed - indexed for MEDLINE]Related articles

Post-exposure prophylaxis.

van der Ende ME, Regez RM, Schreij G, van der Meer JT, Danner SA; Dutch PEP registration.

Int J STD AIDS. 2002 Dec;13 Suppl 2:30-4.PMID: 12537723 [PubMed - indexed for MEDLINE]Related articles

[Treatment adherence amongst HIV-infected patients in Rotterdam: poorer prognosis independent of nationality in heterosexual infected patients, intravenous drug users, Negroid and Latin-American patients]

Kooiman EL, Dieleman JP, Gyssens IC, Nieuwkerk PT, de Marie S, van der Ende ME.

Ned Tijdschr Geneeskd. 2002 Jun 22;146(25):1183-7. Dutch. PMID: 12109310 [PubMed - indexed for MEDLINE]Related articles

Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort.

Wolters LM, Niesters HG, Hansen BE, van der Ende ME, Kroon FP, Richter C, Brinkman K, Meenhorst PL, de Man RA.

J Clin Virol. 2002 Apr;24(3):173-81.PMID: 11856618 [PubMed - indexed for MEDLINE]Related articles

Papillary necrosis associated with the HIV protease inhibitor indinavir.

Dieleman JP, van der Feltz M, Bangma CH, Stricker BH, van der Ende ME.

Infection. 2001 Aug;29(4):232-3.PMID: 11545487 [PubMed - indexed for MEDLINE]Related articles

[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]

Jambroes M, Weverling GJ, Reiss P, Danner SA, Jurriaans S, ten Veen JH, van der Ende ME, Schutten M, Schneider MM, Schuurman R, Mulder JW, Kroes AC, Lange JM, de Wolf F; Kliniek en Virologie van het ATHENA-project.

Ned Tijdschr Geneeskd. 2001 Aug 18;145(33):1591-7. Dutch. PMID: 11534377 [PubMed - indexed for MEDLINE]Related articles

Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy.

Bijl M, Dieleman JP, Simoons M, van der Ende ME.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):318-20. No abstract available. PMID: 11464156 [PubMed - indexed for MEDLINE]Related articles

Ultrastructural localisation of sialoadhesin (siglec-1) on macrophages in rodent lymphoid tissues.

Schadee-Eestermans IL, Hoefsmit EC, van de Ende M, Crocker PR, van den Berg TK, Dijkstra CD.

Immunobiology. 2000 Nov;202(4):309-25. Erratum in: Immunobiology 2001 May;203(4):705. PMID: 11131149 [PubMed - indexed for MEDLINE]Related articles

Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy.

van der Ende ME, Guillon C, Boers PH, Ly TD, Gruters RA, Osterhaus AD, Schutten M.

J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):11-8.PMID: 11064499 [PubMed - indexed for MEDLINE]Related articles

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine.

Gisolf EH, Enting RH, Jurriaans S, de Wolf F, van der Ende ME, Hoetelmans RM, Portegies P, Danner SA.

AIDS. 2000 Jul 28;14(11):1583-9.PMID: 10983645 [PubMed - indexed for MEDLINE]Related articles